152 related articles for article (PubMed ID: 27694793)
1. Y-27632 Increases Sensitivity of PANC-1 Cells to EGCG in Regulating Cell Proliferation and Migration.
Liu X; Bi Y
Med Sci Monit; 2016 Oct; 22():3529-3534. PubMed ID: 27694793
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effects of epigallocatechin-3-gallate on cell proliferation and the expression of HIF-1α and P-gp in the human pancreatic carcinoma cell line PANC-1.
Zhu Z; Wang Y; Liu Z; Wang F; Zhao Q
Oncol Rep; 2012 May; 27(5):1567-72. PubMed ID: 22367292
[TBL] [Abstract][Full Text] [Related]
3. Effects of (-)epigallocatechin gallate and thymoquinone on proliferation of a PANC-1 cell line in culture.
Tan M; Norwood A; May M; Tucci M; Benghuzzi H
Biomed Sci Instrum; 2006; 42():363-71. PubMed ID: 16817635
[TBL] [Abstract][Full Text] [Related]
4. Epigallocatechin-3-Gallate (EGCG) Suppresses Pancreatic Cancer Cell Growth, Invasion, and Migration partly through the Inhibition of Akt Pathway and Epithelial-Mesenchymal Transition: Enhanced Efficacy when Combined with Gemcitabine.
Wei R; Penso NEC; Hackman RM; Wang Y; Mackenzie GG
Nutrients; 2019 Aug; 11(8):. PubMed ID: 31405071
[TBL] [Abstract][Full Text] [Related]
5. Differential proteomic analysis reveals that EGCG inhibits HDGF and activates apoptosis to increase the sensitivity of non-small cells lung cancer to chemotherapy.
Flores-Pérez A; Marchat LA; Sánchez LL; Romero-Zamora D; Arechaga-Ocampo E; Ramírez-Torres N; Chávez JD; Carlos-Reyes Á; Astudillo-de la Vega H; Ruiz-García E; González-Pérez A; López-Camarillo C
Proteomics Clin Appl; 2016 Feb; 10(2):172-82. PubMed ID: 26175166
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effects of (-)-epigallocatechin-3-gallate and pterostilbene on pancreatic cancer growth in vitro.
Kostin SF; McDonald DE; McFadden DW
J Surg Res; 2012 Oct; 177(2):255-62. PubMed ID: 22583593
[TBL] [Abstract][Full Text] [Related]
7. Suppressing glucose metabolism with epigallocatechin-3-gallate (EGCG) reduces breast cancer cell growth in preclinical models.
Wei R; Mao L; Xu P; Zheng X; Hackman RM; Mackenzie GG; Wang Y
Food Funct; 2018 Nov; 9(11):5682-5696. PubMed ID: 30310905
[TBL] [Abstract][Full Text] [Related]
8. PI3K/AKT/mTOR signaling is involved in (-)-epigallocatechin-3-gallate-induced apoptosis of human pancreatic carcinoma cells.
Liu S; Wang XJ; Liu Y; Cui YF
Am J Chin Med; 2013; 41(3):629-42. PubMed ID: 23711146
[TBL] [Abstract][Full Text] [Related]
9. Shining a Light on the Effects of the Combination of (-)-Epigallocatechin-3-gallate and Tapentadol on the Growth of Human Triple-negative Breast Cancer Cells.
Bimonte S; Cascella M; Barbieri A; Arra C; Cuomo A
In Vivo; 2019; 33(5):1463-1468. PubMed ID: 31471393
[TBL] [Abstract][Full Text] [Related]
10. Antiproliferative effects of the major tea polyphenol, (-)-epigallocatechin gallate and retinoic acid in cervical adenocarcinoma.
Yokoyama M; Noguchi M; Nakao Y; Ysunaga M; Yamasaki F; Iwasaka T
Gynecol Oncol; 2008 Feb; 108(2):326-31. PubMed ID: 18035403
[TBL] [Abstract][Full Text] [Related]
11. Prostanoid EP1 receptor as the target of (-)-epigallocatechin-3-gallate in suppressing hepatocellular carcinoma cells in vitro.
Jin J; Chang Y; Wei W; He YF; Hu SS; Wang D; Wu YJ
Acta Pharmacol Sin; 2012 May; 33(5):701-9. PubMed ID: 22555372
[TBL] [Abstract][Full Text] [Related]
12. The green tea catechin epigallocatechin gallate induces cell cycle arrest and shows potential synergism with cisplatin in biliary tract cancer cells.
Mayr C; Wagner A; Neureiter D; Pichler M; Jakab M; Illig R; Berr F; Kiesslich T
BMC Complement Altern Med; 2015 Jun; 15():194. PubMed ID: 26100134
[TBL] [Abstract][Full Text] [Related]
13. PANC-1 pancreatic cancer cell growth inhibited by cucurmosin alone and in combination with an epidermal growth factor receptor-targeted drug.
Wang C; Yang A; Zhang B; Yin Q; Huang H; Chen M; Xie J
Pancreas; 2014 Mar; 43(2):291-7. PubMed ID: 24518510
[TBL] [Abstract][Full Text] [Related]
14. EGCG inhibits proliferation, invasiveness and tumor growth by up-regulation of adhesion molecules, suppression of gelatinases activity, and induction of apoptosis in nasopharyngeal carcinoma cells.
Fang CY; Wu CC; Hsu HY; Chuang HY; Huang SY; Tsai CH; Chang Y; Tsao GS; Chen CL; Chen JY
Int J Mol Sci; 2015 Jan; 16(2):2530-58. PubMed ID: 25625511
[TBL] [Abstract][Full Text] [Related]
15. Identification of epigallocatechin-3-gallate in green tea polyphenols as a potent inducer of p53-dependent apoptosis in the human lung cancer cell line A549.
Yamauchi R; Sasaki K; Yoshida K
Toxicol In Vitro; 2009 Aug; 23(5):834-9. PubMed ID: 19406223
[TBL] [Abstract][Full Text] [Related]
16. Green tea polyphenol EGCG suppresses osteosarcoma cell growth through upregulating miR-1.
Zhu K; Wang W
Tumour Biol; 2016 Apr; 37(4):4373-82. PubMed ID: 26499783
[TBL] [Abstract][Full Text] [Related]
17. Epigallocatechin‑3‑gallate inhibits the proliferation and migration of human ovarian carcinoma cells by modulating p38 kinase and matrix metalloproteinase‑2.
Wang F; Chang Z; Fan Q; Wang L
Mol Med Rep; 2014 Mar; 9(3):1085-9. PubMed ID: 24452912
[TBL] [Abstract][Full Text] [Related]
18. Application of non-invasive low strength pulsed electric field to EGCG treatment synergistically enhanced the inhibition effect on PANC-1 cells.
Hsieh CH; Lu CH; Chen WT; Ma BL; Chao CY
PLoS One; 2017; 12(11):e0188885. PubMed ID: 29186186
[TBL] [Abstract][Full Text] [Related]
19. (-)-Epigallocatechin 3-gallate inhibits invasion by inducing the expression of Raf kinase inhibitor protein in AsPC‑1 human pancreatic adenocarcinoma cells through the modulation of histone deacetylase activity.
Kim SO; Kim MR
Int J Oncol; 2013 Jan; 42(1):349-58. PubMed ID: 23135610
[TBL] [Abstract][Full Text] [Related]
20. Investigation of folate-modified EGCG-loaded thermosensitive nanospheres inducing immunogenic cell death and damage-associated molecular patterns in hepatocellular carcinoma.
He L; Peng L; Wang L; Jiang X; Sun X; Li H; Lin T; Wu Z; Lin S
Biochem Biophys Res Commun; 2024 Jun; 714():149976. PubMed ID: 38677007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
